|
|
|
Jointly sponsored by the American Academy of CME, Inc and
Princeton Media Associates, Program in Medicine Division |
Target Audience
This activity is designed for managed market physicians, pharmacists, and nurses.
Learning Objectives
After completing this activity, participants should be able to:
- Describe the incidence and clinical and cost burden of gastroesophageal reflux disease (GERD) in the United States
- Outline the frequent complications of GERD and the prospective long-term impact of GERD complications on overall health and quality of life
- Define traditional methods for the diagnosis and management of GERD
- Summarize data indicating the potential significance of early diagnosis and management of GERD to improve long-term outcomes
- Apply the latest data to assist in implementation of early and effective strategies for the management of GERD
Credit Eligibility
To be eligible for documentation of credit, participants must attend a full teleconference event, complete the 10-question post-test with a score of 70% or better, and complete the evaluation form. Participants who successfully complete the post-test and evaluation form online may immediately print their documentation of credit. Those who mail or fax back their successfully completed post-test and evaluation form will receive documentation of credit by mail within 6 weeks.
Release Date: May 14, 2007; Expiration Date: May 14, 2008
Estimated time to complete: 1 hour
There is no fee associated with this activity.
Lecture Components
The presentation slides, post-test, and evaluation form are available as a click through via the menu at the top of each page of this educational activity.
CME Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Academy of CME, Inc and Princeton Media Associates, Program in Medicine Division. The American Academy of CME, Inc is accredited by the ACCME to provide continuing medical education for physicians.
The American Academy of CME, Inc designates this activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
To contact the American Academy of CME, Inc, please e-mail dbottinick@academycme.org or call 609-921-6622.
CPE Accreditation
Princeton Media Associates, Program in Medicine Division is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education (ACPE Provider #452) and complies with the Criteria for Quality and Interpretive Guidelines. This activity is approved for 1 hour credit (0.1 CEU) of continuing pharmacy education (ACPE #452-297-07-003-H01).
Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity sponsored or cosponsored by Princeton Media Associates, Program in Medicine Division, may contact the Associate Director of Continuing Education in writing. The Program Coordinator will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Director of Continuing Education of Educational Services may be made for a second level of review.
CNE Accreditation
The American Academy of CME, Inc is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
The American Academy of CME, Inc designates this activity for 1.0 contact hour.
Grant Support
This activity is supported by an educational grant from TAP Pharmaceutical Products, Inc.
Presenters
Presenters/Q&A Panel
John E. Pandolfino
Assistant Professor of Medicine
Northwestern University
Chicago, Illinois
Randolph V. Fugit, PharmD, BCPS
Internal Medicine Clinical Specialist
Denver Veterans Affairs Medical Center
Adjoint Assistant Professor, Pharmacy Practice
University of Colorado Health Sciences Center
Denver, Colorado
Independent Clinical Reviewer
James M. Scheiman, MD
Professor of Medicine
Division of Gastroenterology
University of Michigan Medical Center
Ann Arbor, Michigan
Disclosure Information
In accordance with the disclosure policies of the American Academy of CME, Inc and Princeton Media Associates, Program in Medicine Division, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These policies include resolving all conflicts of interest between faculty and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All faculty members participating in this activity have disclosed all relevant financial relationships with commercial interests. The planners of this activity have reviewed these disclosures and have determined that the faculty relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.
The faculty has reported the following:
Dr. Fugit: Scientific Consultant—TAP Pharmaceuticals
Dr. Pandolfino: Scientific Consultant—AstraZeneca, Medtronic, Santarus; Speaker—AstraZeneca, Medtronic, Santarus, TAP Pharmaceuticals
Dr. Scheiman: Scientific Consultant—AstraZeneca, Bayer, GSK, Horizon Therapeutics, Merck, Novartis, Pfizer, PLx Pharma, Pozen, NiCox; Speaker’s Honoraria—AstraZeneca, Santarus, Takeda
Planning Committee Debra Bottinick, American Academy of CME, Inc; Randy Robbin and John Savage, Princeton Media Associates, Program in Medicine Division; Mary Johnson, Princeton Media Associates have disclosed no relevant financial relationships with any commercial interests.
The American Academy of CME, Inc and Princeton Media Associates, Program in Medicine Division require faculty to inform participants whenever off-label/unapproved uses of drugs or devices are discussed in their presentation.
The faculty has disclosed that no off-label/unapproved uses of drugs or devices will be discussed.
